TGF-β is mostly recognized as a tumor-promoting cytokine by inducing cancer cell migration and invasion (34, 35) and as an immunosuppressive factor by inhibiting the generation and effector function of CD4+ and CD8+ effector T cells (17). The gene discussed is CD4; the disease is cancer.